Back
Capricor Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
CAPR
Capricor Therapeutics
Last Price:
$7.16
Seasonality Move:
38.01%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAPR is experiencing slight buying pressure.
Capricor Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.04 | Sell |
| 20-day SMA: | 9.65 | Sell |
| 50-day SMA: | 10.12 | Sell |
| 200-day SMA: | 13.63 | Sell |
| 8-day EMA: | 8.53 | Sell |
| 20-day EMA: | 9.56 | Sell |
| 50-day EMA: | 10.36 | Sell |
| 200-day EMA: | 11.18 | Sell |
Capricor Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 36.9 | Sell |
| Chaikin Money Flow: | 738186 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.34 - 12.3) | Sell |
| Bollinger Bands (100): | (8.9 - 13.44) | Sell |
Capricor Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 7.24 while CAPR 8-day simple moving average is 9.04, which is a Sell signal.
-
The stock price of CAPR is 7.24 while Capricor Therapeutics 20-day SMA is 9.65, which makes it a Sell.
-
Capricor Therapeutics 50-day simple moving average is 10.12 while CAPR share price is 7.24, making it a Sell technically.
-
CAPR stock price is 7.24 and Capricor Therapeutics 200-day simple moving average is 13.63, creating a Sell signal.
CAPR Technical Analysis vs Fundamental Analysis
Sell
27
Capricor Therapeutics (CAPR)
is a Sell
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a SellThe current Capricor Therapeutics [CAPR] share price is $7.24. The Score for CAPR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
330.9M
Price in USD:
7.24
Share Volume:
2.1M
Capricor Therapeutics 52-Week Range
52-Week High:
23.40
52-Week Low:
3.52
Sell
27
Capricor Therapeutics (CAPR)
is a Sell
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?The Capricor Therapeutics stock price is 7.24 USD today.
-
Will CAPR stock go up or go down?Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Capricor Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is overvalued.
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 7.24 while CAPR 8-day exponential moving average is 8.53, which is a Sell signal.
-
The stock price of CAPR is 7.24 while Capricor Therapeutics 20-day EMA is 9.56, which makes it a Sell.
-
Capricor Therapeutics 50-day exponential moving average is 10.36 while CAPR share price is 7.24, making it a Sell technically.
-
CAPR stock price is 7.24 and Capricor Therapeutics 200-day simple moving average is 11.18, creating a Sell signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.83 per share, and an increase next year of $2.60 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
-
CAPR Moving Average Covergence Divergence (MACD) indicator is -0.81, suggesting Capricor Therapeutics is a Sell
-
Capricor Therapeutics Relative Strength Index (RSI) is 36.9, which suggest Capricor Therapeutics is oversold
-
The Bollinger Bands (25) for Capricor Therapeutics is (8.34 - 12.3), which suggest Capricor Therapeutics is a Sell
-
The Bollinger Bands (100) for Capricor Therapeutics is (8.9 - 13.44), which suggest Capricor Therapeutics is a Sell
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.